One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
ACGT Awards Luncheon: March 30 in New York City
Celebrate ACGT's 20th anniversary and honor Crystal Mackall, MD, with the Edward Netter Leadership Award.
How CAR T cells combined with surgery can treat solid tumors
Researchers at the University of Pennsylvania studied the use of CAR T-cell therapy following surgery for breast cancer.
Oncolytic virus therapy: How viruses can kill tumor cells
ACGT has funded research programs using oncolytic virus therapy for solid tumors like glioblastoma, breast cancer and more.
Relationship between cell and gene therapy and the blood-brain barrier and
The blood-brain barrier can impede immune cells and treatment from reaching brain tumors, but there are ways around this wall.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
34.2
million dollars awarded to groundbreaking research.
63
research fellows awarded grants.
38
top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Carl H. June, MD
University of Pennsylvania
Launching a new era in cell and gene therapy research with the world’s first successful and sustained use of CAR T-cell therapy to cure cancer.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Carl H. June, MD
University of Pennsylvania
Launching a new era in cell and gene therapy research with the world’s first successful and sustained use of CAR T-cell therapy to cure cancer.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Brian Brown, PhD
Icahn School of Medicine at Mount Sinai
Working to harness the power of gene therapy to equip a patient’s own T cells to kill immune-suppressing cells.
Stay up-to-date with us and get involved.
Oct 05, 2022
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today